Digoxin Serum Monitoring with Vibegron Co-Administration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a concern that the use of vibegron for treating overactive bladder may interact with other drugs, particularly those with sensitive pharmacokinetic profiles, potentially altering their therapeutic effects, necessitating monitoring and titration of co-administered drug serum levels to maintain desired clinical outcomes.
Innovation Solution
Monitoring serum digoxin concentrations in patients receiving vibegron and adjusting the digoxin dose accordingly to ensure the desired clinical effect is achieved, either by maintaining or titrating the dose during and after vibegron treatment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If vibegron is co-administered with digoxin, then overactive bladder symptoms are treated, but serum digoxin levels may be altered affecting therapeutic effect
Solution Approach 1:
The patent implements feedback by monitoring serum digoxin concentrations and using this information to adjust the digoxin dose. The method specifies that serum digoxin levels should be monitored before, during, and after vibegron treatment, and the digoxin dose should be adjusted based on these levels to maintain therapeutic effect while avoiding toxicity. This closed-loop feedback mechanism resolves the contradiction by actively managing the drug interaction.
Solution Approach 2:
The patent applies parameter changes by adjusting the digoxin dose based on measured serum concentrations. The method provides specific guidance on dose adjustment thresholds (e.g., reducing digoxin dose when serum levels exceed certain ranges). By dynamically changing the digoxin dosage parameter in response to serum level measurements, the system maintains therapeutic effectiveness while minimizing harmful interactions.
2Reliability
If serum digoxin levels are monitored and dose titrated, then desired clinical effect is maintained, but monitoring and adjustment procedures increase complexity
Solution Approach 1:
The feedback mechanism establishes a systematic approach for monitoring and adjusting digoxin levels. By implementing regular monitoring before, during, and after vibegron treatment, and using predefined adjustment criteria, the system automates much of the decision-making process. This structured feedback loop reduces the complexity burden on individual clinicians while maintaining consistent clinical outcomes.
Data Source
AI summary
The present disclosure is directed to a method of treating overactive bladder comprising orally administering to a patient in need thereof a therapeutically effective amount of vibegron, wherein the patient is concomitantly receiving digoxin, wherein the patient's digoxin serum level is maintained at an amount that results in a desired digoxin clinical effect. This can be achieved by monitoring the patient's digoxin serum level before, during, and/or after vibegron treatment, and either maintaining or titrating the digoxin dose based on that level to achieve the desired clinical effect.